Share
    NEW SEARCH RETURN TO SEARCH RESULTS
Number: 201103345 Principal Investigator: Wagner-Johnston, Nina
Title: A Phase I Study to Investigate the Safety and Clinical Activity of CAL-101 in Combination with Chemotherapeutic Agents and Anti-CD20 mAb in Patients with Relapsed or Refractory Indolent B-cell Non-Hodgkin's Lymphoma, Mantle Cell Lymphoma or Chronic Lymphocytic Leukemia
Phase: I Disease Site: Multiple Sites
Participating Site(s):
 
Main Campus
Map and Directions
 
Contact: 800-600-3606 or info@ccadmin.wustl.edu

Description:
The purpose of this study is to see if an investigational drug named CAL-101 in combination with rituximab and bendamustine is safe to give to people with certain types of cancer and to see how it affects patients and their cancer.
 
More Information:
ClinicalTrials.gov Link
Internal Protocol Documents (requires Siteman administrative database password)